- Home
- ICE vs BMY Comparison
ICE vs BMY Comparison
Compare ICE & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICE
- BMY
- Stock Information
- Founded
- ICE 2000
- BMY 1887
- Country
- ICE United States
- BMY United States
- Employees
- ICE N/A
- BMY N/A
- Industry
- ICE Investment Bankers/Brokers/Service
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ICE Finance
- BMY Health Care
- Exchange
- ICE Nasdaq
- BMY Nasdaq
- Market Cap
- ICE 93.1B
- BMY 94.0B
- IPO Year
- ICE 2005
- BMY N/A
- Fundamental
- Price
- ICE $161.91
- BMY $44.57
- Analyst Decision
- ICE Buy
- BMY Hold
- Analyst Count
- ICE 11
- BMY 15
- Target Price
- ICE $197.27
- BMY $57.64
- AVG Volume (30 Days)
- ICE 3.4M
- BMY 18.1M
- Earning Date
- ICE 10-30-2025
- BMY 10-30-2025
- Dividend Yield
- ICE 1.19%
- BMY 5.55%
- EPS Growth
- ICE 28.91
- BMY N/A
- EPS
- ICE 5.21
- BMY 2.49
- Revenue
- ICE $9,688,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- ICE $8.51
- BMY N/A
- Revenue Next Year
- ICE $5.77
- BMY N/A
- P/E Ratio
- ICE $31.09
- BMY $17.96
- Revenue Growth
- ICE 9.95
- BMY 2.57
- 52 Week Low
- ICE $142.29
- BMY $42.96
- 52 Week High
- ICE $189.35
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- ICE 34.20
- BMY 43.00
- Support Level
- ICE $158.23
- BMY $44.66
- Resistance Level
- ICE $162.95
- BMY $48.58
- Average True Range (ATR)
- ICE 2.73
- BMY 1.19
- MACD
- ICE -0.50
- BMY 0.05
- Stochastic Oscillator
- ICE 26.48
- BMY 25.88
About ICE Intercontinental Exchange Inc.
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data services segment (24% of net revenue).
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.